Bukwang Pharmaceutical Co Ltd (Bukwang Pharmaceutical) is a pharmaceutical company that develops new drugs and pharmaceutical products. The company’s product portfolio includes dexide, chioctaside, levovir, orfil, lonacene, axima, and excel, among others. Its pipeline products include JM-012, MLR-1023, JM-010 and SOL-804. Bukwang Pharmaceutical offers its products in the therapeutic areas of liver disease, respiratory diseases, diabetes, prostate cancer, Parkinson's disease and others. The company offers services such as regulatory development, clinical development, and product development. Its products are used for treating hepatitis B virus, diabetic neuropathy, liver damage, seasonal allergies and bronchial asthma. Bukwang Pharmaceutical is headquartered in Seoul, South Korea.
Bukwang Pharmaceutical Co Ltd premium industry data and analytics
Products and Services
Products | Services | Brands |
---|---|---|
OTC | Clinical Development | DYLASTINE |
Nasal Sprays | Regulatory Development | PANBESY |
Soft Capsules | Product Development Services | TAVEX |
XYZ | XYZ | |
XYZ | XYZ | |
XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2023 | New Products/Services | In April, the company launched Vita Angel Chewable Tablet. |
2022 | Corporate Changes/Expansions | In December, Contera Pharma opened a new research center in Horsholm, north of Copenhagen, Denmark. |
2022 | Regulatory Approval | In October, the company applied for domestic product approval for Lurasidone, a new drug for schizophrenia and bipolar depression, to the Ministry of Food and Drug Safety. |
Competitor Comparison
Key Parameters | Bukwang Pharmaceutical Co Ltd | Daewoong Pharmaceutical Co Ltd | Yungjin Pharm Co Ltd | Whan In Pharm Co Ltd | Seoul Pharma Co Ltd |
---|---|---|---|---|---|
Headquarters | South Korea | South Korea | South Korea | South Korea | South Korea |
City | Seoul | Hwaseong | Seoul | Seoul | Cheongju |
State/Province | - | - | Seoul | - | - |
No. of Employees | 617 | 1,256 | 604 | 663 | 178 |
Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Eel Tae Kim | Head-Manufacturing; Director | Executive Board | - | - |
Lee Woo-Hyun | Chief Executive Officer | Senior Management | - | - |
Yu Hee-Won | Chief Executive Officer | Senior Management | - | - |
Taesook Yoon, Ph.D. | General Manager - New Business Development Team | Senior Management | - | - |
Kwang-Ok Lee, Ph.D. | Managing Director - Bukwang Research Center | Senior Management | - | - |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward